Commitment to innovation and quality
Each year worldwide, almost 50,000 patients with severe blood disease benefit from blood hematopoietic cell transplant, requiring a donor with a consistent genetic profile. They are also 100,000 new patients that are accessing the transplant of solid organs (kidney, liver, heart, lung, pancreas) and gain quality of life.
However, transplanted patients require regular monitoring to prevent graft rejection and the occurrence of infections.
With our partners ONE LAMBDA and CYLEX, we offer to transplant specialists the diagnostic tools for assessing donor-recipient matching as well as a personalized monitoring of transplanted patients.
In Histocompatibility, we offer the full range developed by ONE LAMBDA, allowing the DNA-typing for HLA, KIR and Mica alleles, the detection and identification of anti-HLA antibodies, automation products and an efficient software particularly for monitoring the immunisation of transplanted patients.